Form 8-K - Current report:
SEC Accession No. 0001299933-12-002670
Filing Date
2012-11-30
Accepted
2012-11-30 16:58:42
Documents
1
Period of Report
2012-11-29
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_46561.htm 8-K 9327
  Complete submission text file 0001299933-12-002670.txt   10367
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 121235289
SIC: 2834 Pharmaceutical Preparations